Poor understanding of adverse event frequency descriptions

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1329, 2002-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Automated Method for Detecting Increases in Frequency of Spontaneous Adverse Event Reports over Time

By DuMouchel William   Yuen Nancy   Payvandi Nassrin   Booth Wendy   Rut Andrew   Fram David  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 161-177

Taylor & Francis Ltd

Access to resources Recommend Favorite

Safety and adverse event profile of duloxetine

By Wernicke Joachim F   Gahimer James   Yalcin Ilker   Wulster-Radcliffe Meghan   Viktrup Lars  

Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. : 987-993

Informa Healthcare

Access to resources Recommend Favorite

Understanding and Avoiding Antiretroviral Adverse Events

By  

Current Pharmaceutical Design, Vol. 12, Iss. 9, 2006-03 ,pp. : 1075-1090

Bentham Science Publishers

Access to resources Recommend Favorite

Leflunomide: no increase in hepatic adverse event risk?

By  

Reactions Weekly, Vol. 1, Iss. 1016, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Adverse-Event Profile of Crataegus Spp.: A Systematic Review

By Daniele Claudia  

Drug Safety, Vol. 29, Iss. 6, 2006-01 ,pp. : 523-535

Adis International

Access to resources Recommend Favorite